MedAlliance Launches PRISTINE Study Of SELUTION SLR Drug-Eluting Peripheral Balloon
Executive Summary
SELUTION SLR is the first drug-eluting balloon accepted by the FDA as part of its breakthrough program, according to the company.
You may also be interested in...
MedAlliance Secures $50M To Aid Trials And Commercialization
Trustar Capital’s investment will allow MedAlliance to pursue commercialization of its drug eluting balloon and further its trial efforts.
US FDA Panel To Take Up Lutonix DCB Catheter For Lower-Leg Use Next Month
If approved, the device will be the first drug-coated balloon indicated specifically for use in arteries below the knee.
MedAlliance Brings SELUTION SLR Drug-Eluting Peripheral Balloon To Japan
The Swiss company is rolling out the sirolimus-eluting balloon catheter in Europe and sponsoring trials in the US. The FDA has granted it breakthrough status for three different indications.